Latvia - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, Latvia Hospital Average Length of Stay for Carcinoma in Situ increased 0.4% year on year. With 5.3 Days in 2019, the country was number 3 comparing other countries in Hospital Average Length of Stay for Carcinoma in Situ. Latvia is overtaken by Slovakia, which was number 2 at 5.4 Days and is followed by Germany at 5.2 Days. South Korea lead the ranking with 7.5 Days in 2019, that is a fall of 2.6% compared to 2018. Iceland witnessed the best average annual growth at +10.6% per year, while New Zealand recorded the worst performance at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 5.30 |
| 2018 | 5.40 |
| 2017 | 5.50 |
| 2016 | 4.40 |
| 2015 | 5.60 |
Download all data from 2013 to 2019
How does Latvia rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data |
| 3 |
#3
Latvia
|
5.30 | 2019 | -1.9 % | +0.4 % | View data |
| 4 |
#4
Germany
|
5.20 | 2019 | -1.9 % | -1.5 % | View data |
| 5 |
#5
Israel
|
4.80 | 2019 | +6.7 % | +0.8 % | View data |